Pohoiki Beach appears to be step two of Intel’s process-architecture-optimization development model. Step three, a larger integration of Loihi chips to be called Pohoiki Springs, is scheduled to debut later this year. Neuromorphic design is still in a research phase, but this and similar projects from competitors such as IBM and Samsung should break ground for eventual commoditization and commercial use.
The new Pohoiki Beach builds on the 2017 success of Intel’s Loihi NPU.
Using a new technique, scientists have performed the world’s smallest magnetic resonance imaging to capture the magnetic fields of single atoms. It’s an incredible breakthrough that could improve quantum research, as well as our understanding of the Universe on subatomic scales.
“I am very excited about these results,” said physicist Andreas Heinrich of the Institute for Basic Sciences in Seoul. “It is certainly a milestone in our field and has very promising implications for future research.”
You’re probably most familiar with magnetic resonance imaging, or MRI, as a method used to image internal body structures in medicine. An MRI machine uses highly powerful magnets to induce a strong magnetic field around the body, forcing the spin of the protons in the nuclei of your body’s hydrogen atoms to align with the magnetic field, all without producing side-effects.
Scientists believe even moderate amounts of exercise can slow cognitive decline in people at risk of developing Alzheimer’s disease.
A study published in the journal JAMA Neurology found a total of around 8,900 steps per day appeared to slow rates of cognitive decline and brain volume loss in people who were at high risk. The individuals were considered at risk because of the levels of amyloid beta—a protein thought to play a role in Alzheimer’s— in their brain.
Dr. Jasmeer Chhatwal, Assistant Professor at Harvard Medical School and co-author of the research, told Newsweek: “These results suggest that very achievable levels of physical activity may be protective in those at high risk of cognitive decline and that this effect can be augmented further by lowering vascular risk.” Vascular risk factors include high blood pressure, obesity, smoking, diabetes, he explained.
Posted in biotech/medical, genetics, security
You OWN your DNA data Let’s keep it that way.
EDNA Members monetize their genetic data by selling access to their data direct to researchers. With an average selling price of $350.00 and an average expectancy of up to 200 deals, this can translate to as much as $70,000.00 per person. Intended use and licensing of this data is controlled by smart contract and may include posted bonds provided by researchers to insure confidentiality and security of the data. Don’t give away this highly-valuable property. Claim it for yourself. Opt-In only when YOU decide. It’s your property and you should be in control.
Posted in space
My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself. I read the books and do all the research and share my findings with you!
This video is an interview of Dr. Aubrey de Grey @ SENS on July 17, 2019. My wife, Lauren Nally, was our camerawoman.
- Please consider a donation so I can continue to keep my YouTube ads off: My Bitcoin Cash (BCH) address: qr9gcfv92pzwfwa5hj9sqk3ptcnr5jss2g78n7w6f2 or https://www.paypal.me/BrentNally
- Please consider a donation to SENS: https://www.sens.org/
SHOW NOTES:
- Aubrey’s wikipedia: https://en.wikipedia.org/wiki/Aubrey_de_Grey
- SENS wikipedia: https://en.wikipedia.org/wiki/SENS_Research_Foundation
- like & follow SENS on Facebook: https://www.facebook.com/sensf/?ref=br_rs
- subscribe to Undoing Aging’s YouTube channel: https://www.youtube.com/channel/UCAwxbQhlE6qcTXmKcxkaCGA/videos
- follow Aubrey on Twitter: https://twitter.com/aubreydegrey
- follow SENS on Twitter: https://twitter.com/senstweet
- follow Aubrey on LinkedIn: https://www.linkedin.com/in/aubrey-de-grey-24260b/
- follow SENS on Instagram: https://www.instagram.com/sensresearchfoundation/
0:55 Type “Aubrey de Grey” into YouTube for lots of his lectures & interviews.
1:50 Update on the state of the anti-aging industry & explosion of private sector interest.
5:05 Intro for Aubrey
5:35 My May 30, 2019 interview with Sierra Sciences CEO Dr. Bill Andrews: https://www.youtube.com/watch?v=Tx9yG6iTROQ
6:25 diversity of messaging in anti-aging is increasing.
7:10 My July 10, 2019 interview with BioViva CEO Liz Parrish: https://www.youtube.com/watch?v=oBFTwGPaPr4
8:28 Aubrey shares his updated thoughts on the role of telomerase in cancer in humans.
12:00 Liz had here telomeres tested by SpectraCell Laboratories: https://www.spectracell.com/clinicians/products/telomere-testing/ & LifeLength: https://lifelength.com/
14:10 there has recently been more testing on humans in the field of the biology of aging.
15:44 It’s obvious to Aubrey & I that aging is a big problem but most people still don’t understand this.
18:40 profound difference between how scientists & technologists think.
22:11 Watch the documentary “The Immortalists” about Dr. Aubrey de Grey & Dr. Bill Andrews: https://www.theimmortalists.com/watch/?
22:58 updates on anti-aging investments & research projects.
30:01 stem cell therapy is intended to repair cell loss.
30:50: we have a massive funding problem to reverse human aging.
32:53 we must educate the public that aging is causing 100,000 deaths per day and funding biological age reversal research can change this.
36:52 Is human aging a disease?
44:10 FDA progress to treat age-related diseases/conditions.
47:38 World Health Organization ICD code progress to treat age-related diseases/conditions.
50:02 Trans-NIH Geroscience Interest Group (GSIG)
54:40 “triangular log jam” of funding with governments, scientists and public opinion.
56:30 Aubrey shares why SENS still exists.
1:00:38 Ethereum cryptocurrency founder Vitalik Buterin & other SENS donors.
1:01:55 Undoing Aging is a conference held every spring in Berlin, Germany.
1:04:53 July 2019 is Aubrey’s 2-year anniversary at AgeX as the VP of New Technology Discovery.
1:08:44 Jeff Bezos donated $100 million to Unity Biotechnology, Inc. (not Human Longevity Inc.) in 2018.
1:11:02 (Larry) Ellison Medical Foundation failure in reversing human aging.
1:14:15 Google co-founders creating Calico rather than investing in or donating to SENS
1:21: Aubrey shares details about his lifestyle as well as his recommendations for a healthy lifestyle.
1:24:25 Aubrey looks up to the longevity “foot soldiers“
1:28:42 do what you love as much as you can to avoid excess mental, physical and emotional stress.
1:30:40 Aubrey is following all longevity therapies to determine their safety & effectiveness.
1:32:20 my stem cells story & Aubrey’s feedback.
1:34:58 EmCell in Kyiv, Ukraine is the only company doing fetal stem cells therapy.
1:39:20 exosomes
1:41:00 I’ve had no reply from Ambrosia founder Jesse Karmazin since October 2018.
1:42:51 My March 26, 2019 interview with Dr. Ed Park at Recharge Biomedical: https://www.youtube.com/watch?v=xHgfYKsH0uw&list=UUCwpkla04t…qA&index=6
1:44:31 NAD+
1:47:39 gene therapy
1:53:37 please network on the internet & in person with other longevity enthusiasts to help grow this movement faster.
1:58:48 mitochondria
2:00:48 long lived animals
2:01:49 consider a donation to SENS
- Forever Labs 1 year free cryogenic storage discount code ($250 value): BN801
‘Ruthlessly systematic’ research achieves qubit communication 200 times faster than ever before.
After a thunderous launch on a Saturn V rocket, a three day journey through the unforgiving environment of space and a daring descent in the Lunar Module, you’re here: standing on the Moon. Look around and take in the sights of the surface, just as Apollo 17 astronauts Eugene Cernan and Harrison Schmitt saw it almost 5 decades ago. #Apollo50th
Two important developers of the celebrated Crispr gene-editing technology said they will make it easier for researchers to license their intellectual property, a move aimed at hastening innovation in the burgeoning field.
MilliporeSigma, the life-sciences tools division of German pharmaceutical giant Merck KGaA, and the Broad Institute of MIT and Harvard said researchers will be able to get nonexclusive rights to patents held by both organizations for research purposes with a single license.
Companies will have to pay a licensing fee. Nonprofit and academic institutions will be permitted to license the patents for free, the organizations said in a news release on Thursday.
People with bones damaged by accidents, cancer or aging could one day benefit from bone grafts strengthened with chicken eggshells.
